COPD与肠黏膜屏障相关性的研究进展

doi:10.3969/j.issn.1003-9198.2021.05.021

摘要/Abstract

中图分类号:

R 563

师婷, 杜毓锋. COPD与肠黏膜屏障相关性的研究进展[J]. 实用老年医学, 2021, 35(5): 512-515.

[1] TIELEMANS M M, JASPERS FOCKS J, VAN ROSSUM L G, et al. Gastrointestinal symptoms are still prevalent and negatively impact health-related quality of life: a large cross-sectional population based study in the Netherlands[J]. PLoS One, 2013, 8(7):e69876.
[2] OJHA U C, SINGH D P, CHOUDHARI O K, et al. Correlation of severity of functional gastrointestinal disease symptoms with that of asthma and chronic obstructive pulmonary disease: a multicenter study[J]. Int J Appl Basic Med Res, 2018, 8(2):83-88.
[3] EKBOM A, BRANDT L, GRANATH F, et al. Increased risk of both ulcerative colitis and Crohn’s disease in a population suffering from COPD[J]. Lung, 2008, 186 (3): 167-172.
[4] RUTTEN E P A, LENAERTS K, BUURMAN W A, et al. Disturbed intestinal integrity in patients with COPD: effects of activities of daily living [J]. Chest, 2014, 145 (2): 245-252.
[5] SPROOTEN R T M, LENAERTS K, BRAEKEN D C W, et al. Increased small intestinal permeability during severe acute exacerbations of COPD [J]. Respiration, 2018, 95(5):334-342.
[6] LI H, WU Q, XU L, et al. Increased oxidative stress and disrupted small intestinal tight junctions in cigarette smoke-exposed rats[J]. Mol Med Rep, 2015, 11(6):4639-4644.
[7] TURNER J R. Intestinal mucosal barrier function in health and disease[J]. Nat Rev Immunol, 2009, 9(11):799-809.
[8] VAN DER SLUIS M, DE KONING B A, DE BRUIJN A C, et al. Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection[J]. Gastroenterology, 2006, 131(1):117-129.
[9] SALIM S Y, SODERHOLM J D. Importance of disrupted intestinal barrier in inflammatory bowel diseases[J]. Inflamm Bowel Dis, 2011, 17(1):362-381.
[10]GROSCHWITZ K R, HOGAN S P. Intestinal barrier function: molecular regulation and disease pathogenesis[J]. J Allergy Clin Immunol, 2009, 124(1):3-22.
[11]MORTAZ E, ADCOCK I M, FOLKERTS G, et al. Probiotics in the management of lung diseases [J]. Mediators Inflamm, 2013, 2013:751068.
[12]BRASSARD P, VUTCOVICI M, ERNST P, et al. Increased incidence of inflammatory bowel disease in Québec residents with airway diseases[J]. Eur Respir J, 2015, 45(4):962-968.
[13]XIN X, DAI W, WU J, et al. Mechanism of intestinal mucosal barrier dysfunction in a rat model of chronic obstructive pulmonary disease: An observational study[J]. Exp Ther Med, 2016, 12(3):1331-1336.
[14]KEELY S, TALLEY N J, HANSBRO P M. Pulmonary-intestinal cross-talk in mucosal inflammatory disease[J]. Mucosal Immunol, 2012, 5(1):7-18.
[15]温燕,李家树,李小美,等. 肠黏膜屏障功能对老年重症COPD病人预后评估的临床意义[J].中国老年学杂志, 2017, 37(21):5357-5358.
[16]WU G D, CHEN J, HOFFMANN C, et al. Linking long-term dietary patterns with gut microbial enterotypes[J]. Science, 2011, 334(6052):105-108.
[17]VARRASO R, CHIUVE S E, FUNG T T, et al. Alternate Healthy Eating Index 2010 and risk of chronic obstructive pulmonary disease among US women and men: prospective study[J]. BMJ, 2015, 350:h286.
[18]MACIA L, THORBURN A N, BINGE L C, et al. Microbial influences on epithelial integrity and immune function as a basis for inflammatory diseases[J]. Immunol Rev, 2012, 245(1):164-176.
[19]YOUNG R P, HOPKINS R J, MARSLAND B. The Gut-Liver-Lung Axis. Modulation of the innate immune response and its possible role in chronic obstructive pulmonary disease [J]. Am J Respir Cell Mol Biol, 2016, 54(2):161-169.
[20]GOLLWITZER E S, MARSLAND B J. Microbiota abnormalities in inflammatory airway diseases - Potential for therapy[J]. Pharmacol Ther, 2014, 141(1):32-39.
[21]KONING C J, JONKERS D, SMIDT H, et al. The effect of a multispecies probiotic on the composition of the faecal microbiota and bowel habits in chronic obstructive pulmonary disease patients treated with antibiotics[J]. Br J Nutr, 2010, 103(10):1452-1460.
[22]GIL-CARDOSO K, GINES I, PINENT M, et al. Effects of flavonoids on intestinal inflammation, barrier integrity and changes in gut microbiota during diet-induced obesity[J]. Nutr Res Rev, 2016, 29(2):234-248.
[23]ANHE F F, ROY D, PILON G, et al. A polyphenol-rich cranberry extract protects from diet-induced obesity, insulin resistance and intestinal inflammation in association with increased Akkermansia spp. population in the gut microbiota of mice [J]. Gut, 2015, 64(6):872-883.

COPD与肠黏膜屏障相关性的研究进展

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

Metrics

推荐阅读 10

[1]	周赟, 张影影, 高妍芬. 肺力咳合剂联合噻托溴铵粉雾剂在高龄慢性阻塞性肺疾病病人中的效果观察[J]. 实用老年医学, 2024, 38(10): 1011-1015.
[2]	雷万锋, 马秀红. 老年COPD急性加重期病人血清IL-33/sST2轴表达及其对预后的预测价值[J]. 实用老年医学, 2024, 38(10): 1044-1048.
[3]	徐金燕, 夏聪聪, 杨红美. 老年脑卒中肺部感染风险预测模型的建立及验证[J]. 实用老年医学, 2024, 38(5): 452-437.
[4]	彭泽通, 张尧, 刘斌. 贫血对老年社区获得性肺炎死亡的影响分析[J]. 实用老年医学, 2024, 38(3): 260-264.
[5]	苏雪姣, 刘月, 孙蜀宁. 高龄新型冠状病毒感染老年人外周血液学指标与预后的相关性[J]. 实用老年医学, 2024, 38(3): 291-292.
[6]	张杰斯, 黎艳聪, 卢钻芬, 李明标. 黏液玫瑰单胞菌致COPD急性加重1例及文献分析[J]. 实用老年医学, 2024, 38(3): 322-324.
[7]	王瑞萍, 张妮. COPD病人一氧化碳弥散量与运动耐力、呼吸困难及通气效率的相关性研究[J]. 实用老年医学, 2024, 38(2): 141-144.
[8]	姬泽萱, 冯平, 李峰, 项保利, 冯改霞. 老年男性COPD合并骨质疏松病人睾酮及FGF23、MMP-9水平的变化[J]. 实用老年医学, 2024, 38(2): 176-178.
[9]	周柳青, 周计雪, 柳毅. 抑郁症病人抗抑郁药物治疗中2次发生肺栓塞:2例报道[J]. 实用老年医学, 2024, 38(2): 203-205.
[10]	秦克, 李同林, 华俊萍, 江美芳. 老年COPD稳定期病人经鼻高流量湿化氧疗血清颗粒蛋白前体表达水平及意义[J]. 实用老年医学, 2023, 37(12): 1215-1218.
[11]	李娜, 叶莹, 王鸿林, 周秋红. 老年新型冠状病毒感染病人营养支持的研究进展[J]. 实用老年医学, 2023, 37(11): 1081-1075.
[12]	郭佳丽, 黄淳, 陶子荣, 彭伶丽. 老年新型冠状病毒感染病人俯卧位通气管理的最佳证据总结[J]. 实用老年医学, 2023, 37(11): 1086-1091.
[13]	王雪敬, 邓宝凤, 罗昌春, 赵玉荣, 张爱军, 刘海荣, 赵艳梅. 新型冠状病毒感染期间远程探视系统在老年肿瘤住院病人中的应用[J]. 实用老年医学, 2023, 37(11): 1095-1098.
[14]	陈秋羽, 王展展, 李春华. 肠道菌群相关短链脂肪酸在COPD发病机制中的作用研究进展[J]. 实用老年医学, 2023, 37(11): 1166-1169.
[15]	王世福, 欧宗兴, 符沙沙. 老年COPD相关肺动脉高压病人血管活性肠肽水平及其与高凝、低氧状态和血管内皮功能的相关性[J]. 实用老年医学, 2023, 37(9): 907-910.